280
Views
10
CrossRef citations to date
0
Altmetric
Letters to the Editor

Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study

, , , , , , , , , , , , , & show all
Pages 2752-2754 | Received 21 Sep 2016, Accepted 23 Mar 2017, Published online: 09 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yihao Wang, Lei Huang, Yanni Hua, Hui Liu, Huijuan Jiang, Huaquan Wang, Wei Zhang, Rong Fu & Zonghong Shao. (2021) Impact of iron overload by transfusion on survival and leukemia transformation of myelodysplastic syndromes in a single center of China. Hematology 26:1, pages 874-880.
Read now

Articles from other publishers (8)

WenBin Liu, ZhengWei Tan, YueChao Zhao, YanNa Zhao, XiaoLing Yu, BoLin Wang, FengLin Shen, Ai Mi, JinJian Lan & RuiLan Gao. (2023) Panaxadiol saponin ameliorates ferroptosis in iron-overload aplastic anemia mice and Meg-01 cells by activating Nrf2/HO-1 and PI3K/AKT/mTOR signaling pathway. International Immunopharmacology 118, pages 110131.
Crossref
David J. Young, Xing Fan, Emma M. Groarke, Bhavisha Patel, Ronan Desmond, Thomas Winkler, Andre Larochelle, Katherine R. Calvo, Neal S. Young & Cynthia E. Dunbar. (2022) Long‐term eltrombopag for bone marrow failure depletes iron. American Journal of Hematology 97:6, pages 791-801.
Crossref
Giuseppe A. Palumbo, Sara Galimberti, Wilma Barcellini, Daniela Cilloni, Nicola Di Renzo, Elena Maria Elli, Carlo Finelli, Luca Maurillo, Alessandra Ricco, Pellegrino Musto, Rodolfo Russo & Roberto Latagliata. (2021) From Biology to Clinical Practice: Iron Chelation Therapy With Deferasirox. Frontiers in Oncology 11.
Crossref
Cecilia H. Kim & Heather A. Leitch. (2021) Iron overload-induced oxidative stress in myelodysplastic syndromes and its cellular sequelae. Critical Reviews in Oncology/Hematology 163, pages 103367.
Crossref
Heather A. Leitch & Norbert Gattermann. (2019) Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions. Critical Reviews in Oncology/Hematology 141, pages 54-72.
Crossref
P. Joy Ho, Devendra Hiwase, Raj Ramakrishna, Nicholas Viiala, Ann Solterbeck, Robert Traficante, Evren Zor, Othon L. Gervasio, Laura M. High, David M. Ross & Donald K. Bowden. (2019) Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study. HemaSphere 3:3, pages e224.
Crossref
Heather A. Leitch, Rena Buckstein, Nancy Zhu, Thomas J. Nevill, Karen W.L. Yee, Brian Leber, Mary-Margaret Keating, Eve St. Hilaire, Rajat Kumar, Robert Delage, Michelle Geddes, John M. Storring, April Shamy, Mohamed Elemary & Richard A. Wells. (2018) Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS. Leukemia Research 74, pages 21-41.
Crossref
Norbert Gattermann, Rosa Coll, Lutz Jacobasch, Allameddine Allameddine, Amin Azmon, Laurie DeBonnett, Andreas Bruederle & Jie Jin. (2018) Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int‐1‐risk MDS patients: Results of the phase II KALLISTO trial . European Journal of Haematology 101:2, pages 208-215.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.